Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Margareth Ndomondo-Sigonda

Biographic Data

ID7784968
NAMEMargareth Ndomondo-Sigonda
GIVEN NAMESMargareth
FAMILY NAMENdomondo-Sigonda
SIGNATURENDOMONDO-SIGONDA M
AFFILIATIONSFoundation for Professional Development
ORCID0000-0002-0395-063X
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
AUTHOR COUNT4
EDITOR COUNT0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Best practices in the African Medicines Regulatory Harmonization initiative

    Open Access•Margareth Ndomondo-Sigonda, Samvel Azatyan et al.•ARTICLE•PLOS Global Public Health•2023

    In the African Medicines Regulatory Harmonization initiative, national regulatory authorities (NRAs) within each of Africa’s regional economic communities coordinate their activities, rely on the work of one another and other trusted regulatory authorities, and apply other principles of smart regulation. The first regional medicines regulatory harmonization (MRH) initiative in Africa was launched in 2012, with the goal of accelerating access to q…

  • Harmonization of medical products regulation

    Open Access•Margareth Ndomondo-Sigonda, Jacqui Miot et al.•ARTICLE•BMC Public Health•2021

    The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy

  • Expanding global access to essential medicines

    Open Access•Lukas Roth, Daniel Bempong et al.•ARTICLE•Globalization and Health•2018

    Access to quality-assured medical products improves health and save lives. However, one third of the world's population lacks timely access to quality-assured medicines while estimates indicate that at least 10% of medicine in low- and middle-income countries (LMICs) are substandard or falsified (SF), costing approximately US$ 31 billion annually. National regulatory authorities are the key government institutions that promote access to quality-a…

  • Global health security

    Open Access•David L Heymann, Lincoln Chen et al.•ARTICLE•The Lancet•2015

    The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and impact. Out of this human calamity has come renewed attention to global health security--its definition, meaning, and the practical implications for programmes and policy. For example, how does a government begin to strengthen its core public health capacities, as demanded by the International Health Regulations? What counts as a global health security concern…

No prominent works on this page.

  • Global health security

    Open Access•David L Heymann, Lincoln Chen et al.•ARTICLE•The Lancet•2015

    The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and impact. Out of this human calamity has come renewed attention to global health security--its definition, meaning, and the practical implications for programmes and policy. For example, how does a government begin to strengthen its core public health capacities, as demanded by the International Health Regulations? What counts as a global health security concern…

  • Expanding global access to essential medicines

    Open Access•Lukas Roth, Daniel Bempong et al.•ARTICLE•Globalization and Health•2018

    Access to quality-assured medical products improves health and save lives. However, one third of the world's population lacks timely access to quality-assured medicines while estimates indicate that at least 10% of medicine in low- and middle-income countries (LMICs) are substandard or falsified (SF), costing approximately US$ 31 billion annually. National regulatory authorities are the key government institutions that promote access to quality-a…

  • Harmonization of medical products regulation

    Open Access•Margareth Ndomondo-Sigonda, Jacqui Miot et al.•ARTICLE•BMC Public Health•2021

    The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy

  • Best practices in the African Medicines Regulatory Harmonization initiative

    Open Access•Margareth Ndomondo-Sigonda, Samvel Azatyan et al.•ARTICLE•PLOS Global Public Health•2023

    In the African Medicines Regulatory Harmonization initiative, national regulatory authorities (NRAs) within each of Africa’s regional economic communities coordinate their activities, rely on the work of one another and other trusted regulatory authorities, and apply other principles of smart regulation. The first regional medicines regulatory harmonization (MRH) initiative in Africa was launched in 2012, with the goal of accelerating access to q…

Business (3 works) · Economic growth (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works) · Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Political science (3 works) · Public health (3 works) · Economics (2 works) · Environmental health (2 works) · Harmonization (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae